In this month’s Kieger AG’s Chart of the Month, we focus on the impressive success of Moderna, BioNTech SE/Pfizer and their partners in increasing the production capacity of their COVID-19 mRNA vaccines. Since the initial announcement of 1bn doses for 2021 in July 2020, Moderna and BioNTech/Pfizer have jointly increased capacity by 300% to 4bn for 2021 in just 10/11 months. For 2022, doses have been increased to 6bn from the 1.2bn announced in January.
Happy Birthday! Our Kieger Impact Healthcare Fund is turning 1! On this occasion, we are proud to share our Kieger AG Impact Healthcare Report, where we highlight the progress achieved during the past year and reflect on what have been unparalleled times.
“Sell in May and go away, but remember to come back in September” ... or perhaps October? Most stock markets reached new highs in early September, with economies have seemingly finally put the pandemic behind. At such a "cruising altitude," small turbulences can lead to serious corrections – and the month certainly offered plenty.